Modeling how new tobacco products may affect smoking and health over time
Official title: Modeling the Impact of Novel Tobacco Product use on Smoking and Long-Term Health Outcomes
Funded at University of Michigan at Ann Arbor · NIH-11421839 · Data updated 2026-11-12
A long-running NIH grant from the University of Michigan aims to predict how cigarettes, cigars, and newer products like e-cigarettes could change future smoking patterns and health outcomes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | September 14, 2018 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $596,701 |
| NIH project number | 5U54CA229974-09 |
| Project ID | NIH-11421839 on NIH RePORTER |
Who could benefit from this research
✓Could help
Not applicable here; this grant is model-based research and does not recruit patients.
✕Less likely to help
No direct patient participation is involved in this grant.
What this research studies
This project creates advanced models to forecast how FDA regulatory actions might influence the use of cigarettes, cigars, electronic nicotine delivery systems, and other novel tobacco products. By using national surveys, reviews of existing research, and historical use data, the team will map how people switch between products over time. The results will help estimate potential health effects and inform policy decisions that protect public health. The work focuses on how people behave, how the regulatory actions are analyzed, and the resulting health outcomes across three aims.
Why it matters
Potential benefit: If successful, it could provide policymakers with clearer predictions of health impacts from different tobacco regulations, guiding safer regulations for the public.
How similar studies have gone: Previous tobacco regulation models exist, and this project extends and harmonizes established frameworks to include newer products.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Levy, David Theodore — University of Michigan at Ann Arbor
- Study coordinator: Levy, David Theodore
Related research
Other NIH-funded projects on the same topics.
-
Blood-based markers to identify lung cancer risk in never-smokers
A researchers team at NYU School of Medicine is testing blood tests that might flag higher lung cancer risk in people who have never smoked, helping decide who might need screening.
-
Social stress and smoking: why disadvantaged young adults struggle to quit
This grant looks at how daily social stress affects if and when disadvantaged young adults who smoke can quit and stay quit.
-
BSMART: A program to help people with HIV quit smoking
A program in HIV care settings tests a proven plan to help people with HIV quit smoking, using quick counseling and a switch to quitting medications.
-
BSMAT: Helping people with HIV quit smoking through routine support
A HIV care program in Botswana aims to help people living with HIV quit smoking using a proven 5A brief intervention plus support medication.
-
Improving treatment for people with HIV who smoke and drink in Nairobi, Kenya
A study tests a new plan to help people with HIV in Nairobi quit smoking and reduce heavy drinking, using a low-cost medicine and counseling.
-
I-STOP: a mobile health program to help people with HIV quit smoking
A smartphone-based program designed to help people with HIV quit smoking in a sustainable, affordable way.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.